For the Culture By The Culture
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
A new study claims cannabis can be measured like alcohol using weekly limits and risk tiers. This feature dismantles that framework, exposing how alcohol math distorts cannabis science, ignores human biology, and fuels modern prohibition under the guise of public health. Numbers may comfort regulators, but they do not reflect reality.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
The San Francisco Chronicle’s new article warns that cannabis is dangerous for older adults, but the science says otherwise. Studies show benefits for pain, sleep, and muscle spasticity when used responsibly. The real risk comes from misinformation, fear, and the unregulated hemp market, not from seniors using cannabis with care.
Weather alters every puff. From temperature to barometric pressure, each element changes how THC hits your body and mind. The science of the sky proves that climate, not just strain, determines how high you really get.
A German biotech is pushing a cannabis pill called VER 01 and calling it a breakthrough for pain relief. Beneath the pharmaceutical polish is a deeper story about control, money, and culture. Pot Culture Magazine asks if Vertanical’s lab born weed is progress or just another corporate grab for the plant the people built.
